Preprocedural coronary computed tomography angiography in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry
Introduction
Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) can be challenging to perform, especially in the presence of certain anatomic characteristics such as proximal cap ambiguity, tortuosity, calcification and severely diseased distal vessel. Preprocedural coronary computed tomography (CCTA) can provide accurate assessment of coronary anatomy that could help plan and overcome challenges in CTO PCI [1]. A recent randomized controlled trial demonstrated higher technical success in patients who had preprocedural CCTA guided CTO PCI [2]. However, whether preprocedural CCTA has an impact on CTO PCI outcomes in daily practice has received limited study. We, therefore, evaluated the clinical and angiographic characteristics, contemporary outcomes and the contribution of preprocedural CCTA to procedural planning in a large multicenter CTO PCI registry.
Section snippets
Methods
We compared the clinical and angiographic characteristics, in-hospital procedural outcomes, and the contribution of preprocedural CCTA to procedural planning in the Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS-CTO registry, NCT02061436). PROGRESS-CTO includes patient level data for CTO PCI procedures performed between 2012 and 2022 at experienced CTO PCI centers from the United States, Canada, Greece, Turkey, Egypt, Russia, and Lebanon. All
Results
Of the 7034 CTO PCI procedures performed between 2012 and 2022, preprocedural CCTA was used in 375 (5.3%), with increasing use over time (Fig. 1).
Discussion
The main findings of our study are that preprocedural CCTA was used in ~5% of CTO PCI cases with increasing frequency over time, especially in cases with higher angiographic complexity, and was mainly helpful in resolving proximal cap ambiguity (27%), identifying calcium not seen on angiogram (18%), and changing CTO lesion length (10%) (Fig. 2).
Conclusion
CCTA was used in approximately 5% of CTO PCIs and was most often useful in resolving proximal cap ambiguity followed by identification calcium not seen by conventional angiography. CCTA may facilitate risk/benefit calculation and guide intraprocedural strategy, but was not associated with higher success rates in the present study.
Declaration of Competing Interest
Dr. Jaffer: Sponsored research: Canon, Siemens, Shockwave, Teleflex, Mercator, Boston Scientific; Consultant: Boston Scientific, Siemens, Magenta Medical, IMDS, Asahi Intecc, Biotronik, Philips, Intravascular Imaging. Equity interest – Intravascular Imaging Inc., DurVena. Massachusetts General Hospital – licensing arrangements: Terumo, Canon, Spectrawave, for which FAJ has right to receive royalties.
Dr. Doshi: speaker's bureau for Abbott Vascular, Boston Scientific, and Medtronic and research
Acknowledgements
The authors are grateful for the philanthropic support of our generous anonymous donors, and the philanthropic support of Drs. Mary Ann and Donald A Sens; Mrs. Diane and Dr. Cline Hickok; Mrs. Wilma and Mr. Dale Johnson; Mrs. Charlotte and Mr. Jerry Golinvaux Family Fund; the Roehl Family Foundation; the Joseph Durda Foundation. The generous gifts of these donors to the Minneapolis Heart Institute Foundation's Science Center for Coronary Artery Disease (CCAD) helped support this research
References (19)
- et al.
Effect of coronary CTA on chronic total occlusion percutaneous coronary intervention: a randomized trial
JACC Cardiovasc. Imaging
(2021) - et al.
Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support
J. Biomed. Inform.
(2009) - et al.
The REDCap consortium: Building an international community of software platform partners
J Biomed Inform
(2019) - et al.
Development and validation of a novel scoring system for predicting technical success of chronic Total occlusion percutaneous coronary interventions: the PROGRESS CTO (prospective global registry for the study of chronic Total occlusion intervention) score
JACC Cardiovasc Interv
(2016) - et al.
Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (multicenter CTO registry in Japan) score as a difficulty grading and time assessment tool
JACC Cardiovasc Interv
(2011) - et al.
Predicting Periprocedural complications in chronic Total occlusion percutaneous coronary intervention: the PROGRESS-CTO complication scores
JACC Cardiovasc Interv
(2022) - et al.
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines
J. Am. Coll. Cardiol.
(2022) - et al.
CT angiography for revascularization of CTO: crossing the Borders of diagnosis and treatment
JACC Cardiovasc. Imaging
(2015) - et al.
Derivation and validation of a chronic Total coronary occlusion intervention procedural success score from the 20,000-patient EuroCTO registry: the EuroCTO (CASTLE) score
JACC Cardiovasc Interv
(2019)
Cited by (0)
- 1
This author takes responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation